NCT03122197View on ClinicalTrials.gov

Study of Letrozole in Recurrent Gliomas

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

September 1, 2024

Study Completion Date

December 31, 2024

Conditions
Brain Tumor
Interventions
DRUG

Letrozole Oral Tablet

Administration: Letrozole will be given orally once daily.

DRUG

Temozolomide

50 mg/m2 TMZ administered orally once daily

Trial Locations (1)

45267

RECRUITING

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER